MedTrace Logo

The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma

NCT05100368 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-07-20

No results posted yet for this study

Summary

Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020

Conditions

  • Sarcoma, Ewing

Interventions

OTHER

patients

Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-02
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100368 on ClinicalTrials.gov